Shanghai Retained Earnings from 2010 to 2025
| 601607 Stock | 20.15 0.32 1.61% |
Retained Earnings | First Reported 2000-06-30 | Previous Quarter 35.2 B | Current Value 36.1 B | Quarterly Volatility 12.1 B |
Check Shanghai Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 2 B, Selling General Administrative of 6.7 B or Total Revenue of 314.3 B, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Pharmaceuticals Valuation or Volatility modules.
Shanghai | Retained Earnings |
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.